A Study to Investigate the Effect of PH-797804 on QTc Interval

NCT01862887 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: PH-797804
DRUG: Moxifloxacin
DRUG: Placebo

Sponsor

Pfizer